Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy in malignant melanoma: recent approaches and new perspectives.
Arasanz H, Lacalle A, Lecumberri MJ, de Lascoiti ÁF, Blanco-Luquin I, GatoCañas M, Pérez-Ricarte L, Zuazo M, Kochan G, Escors D. Arasanz H, et al. Melanoma Manag. 2017 Mar;4(1):39-48. doi: 10.2217/mmt-2016-0019. Epub 2017 Mar 1. Melanoma Manag. 2017. PMID: 30190903 Free PMC article. Review.
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.
Liechtenstein T, Perez-Janices N, Gato M, Caliendo F, Kochan G, Blanco-Luquin I, Van der Jeught K, Arce F, Guerrero-Setas D, Fernandez-Irigoyen J, Santamaria E, Breckpot K, Escors D. Liechtenstein T, et al. Oncotarget. 2014 Sep 15;5(17):7843-57. doi: 10.18632/oncotarget.2279. Oncotarget. 2014. PMID: 25151659 Free PMC article.
EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.
Perez-Janices N, Blanco-Luquin I, Tuñón MT, Barba-Ramos E, Ibáñez B, Zazpe-Cenoz I, Martinez-Aguillo M, Hernandez B, Martínez-Lopez E, Fernández AF, Mercado MR, Cabada T, Escors D, Megias D, Guerrero-Setas D. Perez-Janices N, et al. Oncotarget. 2015 Jan 1;6(1):368-80. doi: 10.18632/oncotarget.2745. Oncotarget. 2015. PMID: 25621889 Free PMC article.
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy.
Liechtenstein T, Perez-Janices N, Blanco-Luquin I, Goyvaerts C, Schwarze J, Dufait I, Lanna A, Ridder M, Guerrero-Setas D, Breckpot K, Escors D. Liechtenstein T, et al. Oncoimmunology. 2014 Jul 3;3(7):e945378. doi: 10.4161/21624011.2014.945378. eCollection 2014. Oncoimmunology. 2014. PMID: 25954597 Free PMC article.
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage.
Gato-Cañas M, Martinez de Morentin X, Blanco-Luquin I, Fernandez-Irigoyen J, Zudaire I, Liechtenstein T, Arasanz H, Lozano T, Casares N, Chaikuad A, Knapp S, Guerrero-Setas D, Escors D, Kochan G, Santamaría E. Gato-Cañas M, et al. Oncotarget. 2015 Sep 29;6(29):27160-75. doi: 10.18632/oncotarget.4746. Oncotarget. 2015. PMID: 26320174 Free PMC article.
Drafting the proteome landscape of myeloid-derived suppressor cells.
Gato M, Blanco-Luquin I, Zudaire M, de Morentin XM, Perez-Valderrama E, Zabaleta A, Kochan G, Escors D, Fernandez-Irigoyen J, Santamaría E. Gato M, et al. Proteomics. 2016 Jan;16(2):367-78. doi: 10.1002/pmic.201500229. Epub 2015 Dec 14. Proteomics. 2016. PMID: 26403437 Review.
[Dendritic cells in cancer immunotherapy].
Gato M, Liechtenstein T, Blanco-Luquín I, Zudaire MI, Kochan G, Escors D. Gato M, et al. An Sist Sanit Navar. 2015 May-Aug;38(2):279-87. doi: 10.23938/ASSN.0077. An Sist Sanit Navar. 2015. PMID: 26486534 Free article. Spanish.
35 results